179 POSTER Phase I study of the novel anti-cancer drug PM00104 as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors or lymphoma

✍ Scribed by J.C. Soria; R. Plummer; A. Soto; C. Massard; H. Calvert; R. Prados; E. Angevin; C. Jones; B. de las Heras

• Book ID: 119599334
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 62 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)72111-6